Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2007 1
2017 2
2018 1
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
RENASCENT III: First in Human Evaluation of the Novel Thin Strut MAGNITUDE Sirolimus-Eluting Ultra-High Molecular Weight MAGNITUDE Bioresorbable Scaffold: 9-Month Imaging and 2-Year Clinical Results.
Ferrone M, Chieffo A, Khawaja SA, Moncada M, Colombo A, Latib A, Esposito G, Stabile E, Avvedimento M, Bedogni F, Testa L, Delgado JA, Arana C, Vesga B, Cortese B, Mahera A, Granada JF. Ferrone M, et al. Among authors: vesga b. Circ Cardiovasc Interv. 2021 May;14(5):e010013. doi: 10.1161/CIRCINTERVENTIONS.120.010013. Epub 2021 May 18. Circ Cardiovasc Interv. 2021. PMID: 34003665 No abstract available.
Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial).
Dudek D, Ebner A, Sobczyński R, Trębacz J, Vesga B, Granada J, Zembala M, Witkowski A, Van Mieghem NM, Sood P, Ochała A, Dziewierz A, Żmudka K. Dudek D, et al. Among authors: vesga b. Am J Cardiol. 2018 Jun 15;121(12):1524-1529. doi: 10.1016/j.amjcard.2018.02.046. Epub 2018 Mar 13. Am J Cardiol. 2018. PMID: 29655880
[Neuroepidemiology in the eastern region of Colombia].
Pradilla G, Vesga BE, Leon-Sarmiento FE, Bautista LE, Núñez LC, Vesga E, Gamboa NR; Grupo GENECO. Pradilla G, et al. Among authors: vesga be. Rev Neurol. 2002 Jun 1-15;34(11):1035-43. Rev Neurol. 2002. PMID: 12134301 Free article. Spanish.
First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial.
Chieffo A, Khawaja SA, Latib A, Vesga B, Moncada M, Delgado JA, Fonseca J, Testa L, Esposito G, Ferrone M, Cortese B, Maehara A, Granada JF, Colombo A; Collaborators. Chieffo A, et al. Among authors: vesga b. EuroIntervention. 2020 Jun 12;16(2):e133-e140. doi: 10.4244/EIJ-D-19-00600. EuroIntervention. 2020. PMID: 32149709 Free article. Clinical Trial.
First in human evaluation of a novel Sirolimus-eluting ultra-high molecular weight bioresorbable scaffold: 9-, 24-and 36-months imaging and clinical results from the multi-center RENASCENT study.
Chieffo A, Khawaja SA, Vesga B, Hernandez H, Moncada M, Delgado JA, Esposito G, Ferrone M, Dager A, Arana C, Stabile E, Meliga E, De Benedictis M, Montorfano M, Latib A, Fonseca J, Gomez G, Tamburino C, Tarantini G, La Manna A, Maehara A, Granada JF, Colombo A. Chieffo A, et al. Among authors: vesga b. Int J Cardiol. 2020 Dec 15;321:48-53. doi: 10.1016/j.ijcard.2020.08.014. Epub 2020 Aug 15. Int J Cardiol. 2020. PMID: 32810542